Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.
暂无分享,去创建一个
D. Geddes | M. O'Doherty | P. Blower | D M Geddes | S H Thomas | M J O'Doherty | A Graham | C J Page | P Blower | T O Nunan | T. Nunan | C. Page | S. Thomas | A. Graham
[1] M. Knowles,et al. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. , 1981, The New England journal of medicine.
[2] M. O'Doherty,et al. Pulmonary deposition of nebulised pentamidine isethionate: effect of nebuliser type, dose, and volume of fill. , 1990, Thorax.
[3] S. Anderson,et al. Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline. , 1981, British medical journal.
[4] J. Gatzy,et al. Deposition, clearance, and effects of aerosolized amiloride in sheep airways. , 1986, The American review of respiratory disease.
[5] S. Clarke,et al. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. , 1988, Thorax.
[6] M. K. James,et al. Acute cardiovascular and pulmonary effects of intravenous and aerosolized amiloride in the dog. , 1987, Toxicology and applied pharmacology.
[7] M. Newhouse,et al. The effects of preferential deposition of histamine in the human airway. , 2015, The American review of respiratory disease.
[8] M. King,et al. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy. , 1990, The American review of respiratory disease.
[9] M. King,et al. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. , 1990, The New England journal of medicine.
[10] J. L. Potter,et al. Studies on pulmonary secretions. II. Osmolality and the ionic environment of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. , 1967, The American review of respiratory disease.
[11] J. Markham,et al. The measurement of regional ventilation in man: a new method of quantitation. , 1973, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] M. Knowles,et al. Bioelectric properties and ion flow across excised human bronchi. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.
[13] M. O'Doherty,et al. DIFFERENCES IN RELATIVE EFFICIENCY OF NEBULISERS FOR PENTAMIDINE ADMINISTRATION , 1988, The Lancet.
[14] M. O'Doherty,et al. Which apparatus for inhaled pentamidine? A comparison of pulmonary deposition via eight nebulisers. , 1991, The European respiratory journal.
[15] G. Smaldone,et al. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. , 1987, The American review of respiratory disease.
[16] J. Elborn,et al. Cystic fibrosis. 2. Lung injury in cystic fibrosis. , 1990, Thorax.
[17] C. Hardy. Inhaler therapy. , 1991, The Practitioner.
[18] M. Knowles,et al. Evidence for reduced Cl‐ and increased Na+ permeability in cystic fibrosis human primary cell cultures. , 1988, The Journal of physiology.